tiprankstipranks
Innate Pharma SA (FR:IPH)
:IPH
France Market

Innate Pharma SA (IPH) Technical Analysis

Compare
4 Followers

Summary of all the Indicators

Overall Consensus
Strong Buy
15Bullish
4Neutral
3Bearish
Technical Analysis Consensus
Neutral
3Bullish
4Neutral
3Bearish
Moving Average Consensus
Strong Buy
12Bullish
0Neutral
0Bearish
Innate Pharma SA’s (IPH) Moving Averages Convergence Divergence (MACD) indicator is 0.08, suggesting Innate Pharma SA is a Sell.
Innate Pharma SA’s (IPH) 20-Day exponential moving average is 1.93, while Innate Pharma SA’s (IPH) share price is €2.1, making it a Buy.
Innate Pharma SA’s (IPH) 50-Day exponential moving average is 1.85, while Innate Pharma SA’s (IPH) share price is €2.1, making it a Buy.

Innate Pharma SA (IPH) Pivot Points

Feb 21, 2025, 08:29 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
1.52
1.79
1.96
2.23
2.40
2.67
2.84
Fibonacci
1.79
1.96
2.06
2.23
2.40
2.50
2.67
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Innate Pharma SA (IPH) Moving Averages

Feb 21, 2025, 08:29 AM
Period
Simple
Exponential
MA5
2.04Buy
2.07Buy
MA10
1.99Buy
2.00Buy
MA20
1.89Buy
1.93Buy
MA50
1.86Buy
1.85Buy
MA100
1.77Buy
1.85Buy
MA200
1.96Buy
1.98Buy
Innate Pharma SA’s (IPH) 10-Day exponential moving average is 2.00, while Innate Pharma SA’s (IPH) share price is €2.1, making it a Buy.
Innate Pharma SA’s (IPH) 100-Day exponential moving average is 1.85, while Innate Pharma SA’s (IPH) share price is €2.1, making it a Buy.
Innate Pharma SA’s (IPH) stock price is €2.1 and Innate Pharma SA’s (IPH) 50-day simple moving average is 1.86, creating a Buy signal.
Innate Pharma SA’s (IPH) stock price is €2.1 and Innate Pharma SA’s (IPH) 100-day simple moving average is 1.77, creating a Buy signal.
Innate Pharma SA’s (IPH) stock price is €2.1 and Innate Pharma SA’s (IPH) 200-day simple moving average is 1.96, creating a Buy signal.

Innate Pharma SA (IPH) Technical Indicators

Feb 21, 2025, 08:29 AM
Name
Value
Implied Action
RSI (14)
71.73
Sell
STOCH (9,6)
65.12
Neutral
STOCHRSI (14)
69.16
Neutral
MACD (12,26)
0.08
Sell
ADX (14)
42.67
Neutral
Williams %R
-44.81
Buy
CCI (14)
137.66
Sell
ATR (14)
0.12
-
Ultimate Oscillator
47.06
Neutral
ROC
23.42
Buy
Innate Pharma SA’s (IPH) Relative Strength Index (RSI) is 71.73, creating a Sell signal.
Innate Pharma SA’s (IPH) Trend Strength Indicator (ADX) is 42.67, creating a Neutral signal.
Innate Pharma SA’s (IPH) Commodity Channel Index (CCI) is 137.66, creating a Sell signal.
Innate Pharma SA’s (IPH) Price Rate of Change (ROC) is 23.42, creating a Buy signal.

FAQ

Is IPH a Buy, Hold, or Sell?
Based on IPH’s technical indicators, IPH is a Strong Buy.
    What is IPH’s RSI (14)?
    IPH’s RSI (14) is 71.73, which suggests IPH is a Sell.
      What is IPH’s MACD?
      IPH’s MACD is 0.08, which suggests IPH is a Sell.
        What is IPH’s 5-day moving average?
        IPH’s 5-day moving average is 2.04, which suggests IPH is a Buy.
          What is IPH’s 20-day moving average?
          IPH 20-day moving average is 1.89, which suggests IPH is a Buy.
            What is IPH’s 50-day moving average?
            IPH’s 50-day moving average is 1.86, which suggests IPH is a Buy.
              What is IPH’s 200-day moving average?
              IPH’s 200-day moving average is 1.96, which suggests IPH is a Buy.
                What is IPH’s Williams % R (14)?
                IPH’s Williams % R (14) is -44.81, which suggests IPH is a Buy.
                  What is IPH’s CCI (14)?
                  IPH’s CCI (14) is 137.66, which suggests IPH is a Sell.
                    What is the share price of Innate Pharma SA?
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis